布地奈德雾化吸入治疗慢性阻塞性肺疾病50例分析  

Analysis of 50 Chronic Asthmatic Bronchitis Patients with Budesonide Inhalation Therapy

作　　者：郭万春[1] 徐东兰[1] 李文英[1] 

机构地区：[1]四川省自贡市第四人民医院呼吸内科,自贡643000

出　　处：《当代护士（下旬刊）》2015年第5期33-34,共2页Modern Nurse

摘　　要：目的观察布地奈德雾化吸入治疗慢性阻塞性肺疾病的疗效。方法将50例慢性阻塞性肺疾病患者随机分为治疗组和对照组,每组各25例。两组均予常规抗感染、平喘、止咳、吸O2和对症处理,治疗组加用布地奈德混悬液2 ml(1mg)雾化吸入,每天2次;观察两组治疗后咳嗽、咯痰、喘息、呼吸困难、血气分析和肺功能改善情况,进行临床疗效分析。结果治疗组气喘、咳嗽、呼吸困难方面的改善明显优于对照组,差异有统计学意义(P<0.05),治疗组总有效率明显高于对照组,治疗组患者在治疗期间未发生口腔真菌感染等明显的不良反应。结论布地奈德混悬剂雾化吸入治疗慢性阻塞性肺疾病的疗效明显,能明显改善患者的临床症状和肺功能情况,缩短病程,安全性较好,充分做好雾化吸入的各项护理是确保治疗有效,减少副作用的重要措施。Objective To observe the efficacy of budesonide inhalation therapy and nursing in chronic asthmatic bronchitis. Methods 50 cases of asthmatic bronchitis distributed randomly divided into treatment and control groups were conventional anti-infection,asthma,cough, suck 02 and symptomatic treatment, the treatment group received budesonide 2ml （ling）atomization inhalation, 2 times a day; observed two groups of patients after treatment of cough, expectoration, wheezing, difficulty breathing, blood gas analysis and pulmonary function improve- ment, clinical efficacy analysis.Results The treatment group wheezing, coughing, breathing difficulties than the control group （P〈0.05） , the total efficiency of the treatment group was significantly higher in patients treated with oral fungal infections and other significant adverse reac- tions did not occur during treatment.Conclusion budesonide inhalation suspension asthmatic bronchitis therapeutic effect is obvious, it can significantly improve the clinical symptoms and the patient＇s lung function, shorten the course, also it＇ s security is better, to do all the care of inhalation is an important measure to ensure that treatment is effective to reduce the side effects.

关 键 词：慢性阻塞性肺疾病 布地奈德 雾化吸入 

分 类 号：R473.5[医药卫生—护理学]